BASALIT: Birch Associated Soy Allergy and Immuno-Therapy

A multi centre randomised placebo-controlled double-blind clinical trial for the evaluation of efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed recombinant hypoallergenic derivative of the major birch pollen allergen r Bet v1-FV on Bet v 1 associated soy allergy (Birch Associated Soy Allergy and Immuno-Therapy)

Coordinating investigators: Prof. Dr. Jan C. Simon Prof. Dr. Regina Treudler Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig
Sponsor: Universität Leipzig Ritterstr. 26, 04109 Leipzig

Sponsor: Leipzig University (Sponsor)

SEEK ID: https://ldh.zks.uni-leipzig.de/projects/3

Funding codes:
  • Bundesministerium für Bildung und Forschung Förderkennzeichen: 01KG0911

Public web page: https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011737-27/DE

ZKS Leipzig PIs: Prof. Dr. med. Jan C. Simon, Prof. Dr. med. Regina Treudler

Trial Project created: 3rd Apr 2023

Trial Project end date: 18th Jul 2014

Extended Metadata (Nfdi4Health MDS 3.3)
help Tags

This item has not yet been tagged.

Powered by
(v.1.15.2)
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH